Načítá se...
Decitabine Treatment of Glioma-Initiating Cells Enhances Immune Recognition and Killing
Malignant gliomas are aggressive brain tumours with very poor prognosis. The majority of glioma cells are differentiated (glioma-differentiated cells: GDCs), whereas the smaller population (glioma-initiating cells, GICs) is undifferentiated and resistant to conventional therapies. Therefore, to bett...
Uloženo v:
Vydáno v: | PLoS One |
---|---|
Hlavní autoři: | , , , , , , , , , , , , , |
Médium: | Artigo |
Jazyk: | Inglês |
Vydáno: |
Public Library of Science
2016
|
Témata: | |
On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5007044/ https://ncbi.nlm.nih.gov/pubmed/27579489 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0162105 |
Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|